|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print September 3, 2002
Am J Physiol Endocrinol Metab, 10.1152/ajpendo.00102.2002
Submitted on March 7, 2002
Accepted on August 28, 2002
1 Department of Allergy, Schering-Plough Research Institute, Kenilworth, NJ, USA
* To whom correspondence should be addressed. E-mail: nansie.mchugh{at}spcorp.com.
Anesthetized Sprague-Dawley weanling rats were scanned for bone mineral density (BMD) values after 7 days treatment to determine if resorption/growth at the proximal tibia can be quantified by pQCT scanning techniques. Because the weanling rat is in a rapid growth stage, all groups showed significant increases in change from baseline values of BMD. Bisphosphonate treatment produced significant dose-related changes in BMD with average increases of 195% and 241% (10µg/kg and 20µg/kg) versus 86% in control rats. We further characterized this model to determine effects of steroids on growing bone. Graded doses of glucocorticoid (3.5, 7.0, 10.5, 14.0, 28.0 and 42.0mg/kg/week) caused no significant differences in trabecular BMD in 7 days between control and treated. Significant decreases in growth (weights) and increases in cortical bone area were observed indicating this model may be useful in comparing effects of non-steroid, anti-inflammatory alternatives on juvenile bone. Although the relevance of this model to adult disease remains to be elucidated, it also provides a tool for mechanistic evaluation of therapeutic modalities, or efficacy assessment for dose selection for longer term models.
This article has been cited by other articles:
![]() |
N. A. McHugh, H. M. Vercesi, R. W. Egan, and J. A. Hey Receptor activator of NF-{kappa}B ligand arrests bone growth and promotes cortical bone resorption in growing rats J Appl Physiol, August 1, 2003; 95(2): 672 - 676. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |